• Search
  • Login
  • Register
Menu
  • BJH
  • Home
  • News
    • Newsroom
    • Links
  • CongressUpdate
  • Guidelines
  • Specials
  • Hematotrials
  • Patients
All
  • All
  • BJH articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here
News > EHA 2019

Category

All
  • Healthy Living
  • Pharma News
  • Fundraising
  • Prevention
  • Science
  • Clinical trials
  • Clinical practice
  • Corona
  • Medical Research
  • Health Innovation
  • Art on View

EHA 2019

Frontline brentuximab vedotin + AVD provides durable benefit over ABVD in patients with stage ...

Read more
subscribe Latest issue All issues Newsletters
Index latest issue
  • Fertility preservation in women before cancer therapy
  • Recent advances in the genomic and epigenomic biology of juvenile myelomonocytic leukaemia
  • BHS guidelines for the treatment of newly diagnosed diffuse large B-cell lymphoma (DLBCL) anno 2020
  • Guidelines of the Belgian Hematological Society for newly diagnosed and relapsed follicular lymphoma anno 2019
  • Rituximab induced serum sickness or immune complex deposition disease: case report and desensitisation protocol
  • Journal Scan
  • New haematology reimbursements in Belgium
EHA 2019

Acalabrutinib delays disease progression in patients with relapsed/refractory chronic lymphocy...

Read more
EHA 2019

Voxelotor induces robust improvements in anemia in patients with sickle cell disease

Read more
Top
  • About BJH
  • Advertisements & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJH is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJH 2025